Can methyldopa influence inflammatory cytokine levels in hypertensive patients and what are the implications for inflammation-related complications?
Lakshya KumarExplorer
Can methyldopa influence inflammatory cytokine levels in hypertensive patients?
Share
Methyldopa may reduce inflammatory cytokines in hypertensive patients, potentially decreasing risks of inflammation-related complications like cardiovascular diseases.